Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2004 | 1 |
2007 | 1 |
2008 | 1 |
2009 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Busulfan in hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant. 2009 May;15(5):523-36. doi: 10.1016/j.bbmt.2008.12.489. Epub 2009 Feb 12.
Biol Blood Marrow Transplant. 2009.
PMID: 19361744
Free PMC article.
Review.
Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS.
de Lima M, Couriel D, Thall PF, Wang X, Madden T, Jones R, Shpall EJ, Shahjahan M, Pierre B, Giralt S, Korbling M, Russell JA, Champlin RE, Andersson BS.
de Lima M, et al.
Blood. 2004 Aug 1;104(3):857-64. doi: 10.1182/blood-2004-02-0414. Epub 2004 Apr 8.
Blood. 2004.
PMID: 15073038
Free article.
Item in Clipboard
Pharmacokinetics of once-daily IV busulfan as part of pretransplantation preparative regimens: a comparison with an every 6-hour dosing schedule.
Madden T, de Lima M, Thapar N, Nguyen J, Roberson S, Couriel D, Pierre B, Shpall EJ, Jones RB, Champlin RE, Andersson BS.
Madden T, et al.
Biol Blood Marrow Transplant. 2007 Jan;13(1):56-64. doi: 10.1016/j.bbmt.2006.08.037.
Biol Blood Marrow Transplant. 2007.
PMID: 17222753
Free article.
Clinical Trial.
Item in Clipboard
Reduced-toxicity conditioning therapy with allogeneic stem cell transplantation for acute leukemia.
Andersson BS, de Lima M, Thall PF, Madden T, Russell JA, Champlin RE.
Andersson BS, et al.
Curr Opin Oncol. 2009 Jun;21 Suppl 1(Suppl 1):S11-5. doi: 10.1097/01.cco.0000357469.83960.12.
Curr Opin Oncol. 2009.
PMID: 19561406
Free PMC article.
Item in Clipboard
Once daily i.v. busulfan and fludarabine (i.v. Bu-Flu) compares favorably with i.v. busulfan and cyclophosphamide (i.v. BuCy2) as pretransplant conditioning therapy in AML/MDS.
Andersson BS, de Lima M, Thall PF, Wang X, Couriel D, Korbling M, Roberson S, Giralt S, Pierre B, Russell JA, Shpall EJ, Jones RB, Champlin RE.
Andersson BS, et al.
Biol Blood Marrow Transplant. 2008 Jun;14(6):672-84. doi: 10.1016/j.bbmt.2008.03.009.
Biol Blood Marrow Transplant. 2008.
PMID: 18489993
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite